Edition:
India

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

45.64USD
19 Mar 2019
Change (% chg)

-- (--)
Prev Close
$45.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
206,502
52-wk High
$74.75
52-wk Low
$32.19

Chart for

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $1,913.33
Shares Outstanding(Mil.): 36.34
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates